A newly modified semimicro plaque reduction neutralization test (PRNT) in BHK cells was compared with a standard PRNT in bottles with LLC-MK2 monolayers and with an LLC-MK2 PRNT adapted to semimicro methods. The BHK semimicro PRNT compared favorably in terms of sensitivity in detecting dengue antibody (96%), specificity at a screening dilution (95%), and ability to detect seroconversion to dengue viruses of three serotypes (93%). Disagreements between the BHK test and the LLC-MK2 tests were attributed to greater sensitivity of the BHK test in detecting dengue type 2 (DEN-2) antibody in acute-phase sera and to apparent low-level DEN-1I/DEN-3 cross-reactions in some sera in all three tests. The BHK PRNT was easier, faster, and more economical than either of the LLC-MK2 tests. Many of the benefits of the BHK PRNT derive from the fact that cells are infected while still in suspension, at the time of cell splitting, hence the term "BHK suspension test."
Standard antibody assays such as hemagglutination inhibition, complement fixation, and enzyme-linked immunosorbent assays are of limited value in dengue diagnosis and seroepidemiologic study because they often cannot identify the infecting serotype. Assay of neutralizing antibody is more specific and of similar sensitivity for individuals immune to a single dengue type, but detection of neutralization by standard plaque reduction methods (8) in glass prescription bottles ("macro test") is time consuming and expensive and requires relatively large serum volumes, precluding the use of blood obtained by finger-stick and drawn into capillary tubes or adsorbed onto filter paper. Several micro or semimicro methods for detecting dengue antibodies have been described (1, 3, 5, 6, 9, 10) , but none is widely accepted. In some cases these tests are difficult to perform or interpret or require reagents of limited availability. An ideal test system should retain the simplicity and small-scale attributes of the best micro-method tests along with the sensitivity, specificity, and reproducibility of the macro test. We recently reported a simplified plaque reduction neutralization test (PRNT) adapted to semimicro methods in LLC-MK2 cells that was comparable in sensitivity and specificity to the standard macro test in bottles and required only microvolumes of serum (15 to 25 ,ul) to measure antibody titers to all four dengue serotypes at a screening dilution (D. M. Morens, S. B. Halstead, and L. K. Larsen, submitted for publication). Here we report an improved semimicro PRNT in BHK cells which is of comparable sensitivity and specificity and which has the additional advantages of being less time-consuming, less expensive, simpler to perform and interpret, and capable of providing final results in 5 to 7 days. The major improvements in this assay over previous assays described by us (Table 2) . Exceptions (pairs 24010-24332, 17986-91918, and 73106-22981) were sera with a broad heterotypic pattern. Examination of Table 2 suggests that in these instances determination of infecting type could be confounded by a one-directional DEN-1/DEN-3 cross-reaction, that is, a cross detected in neutralization of sera selected for DEN-1 neutralizing activity, but not of sera selected for DEN-3 neutralizing activity, but the data do not indicate which of the two tests identifies the true infecting serotype.
Comparison of plaque size and morphology. Dengue virus plaques in BHK suspension-infected monolayers were detectable as early as day 5 and no later than day 7, depending upon the infecting serotype and strain. For the three laboratory-adapted serotype strains (Fig. 1) , distinct and readily countable plaques were present by day 5 for DEN-2 and no later than day 7 for DEN-1 and DEN-3. Plaques produced by the wild strains of DEN-2 were sometimes indistinct on day 5, but were always countable by day 6 or 7. Determination of when to stain the plates was based upon experience with the particular strain and, in the case of "new" strains, by direct visualization of plaques in unstained plates by low-power light microscopy. Generally, plaque size increased rapidly over the first 2 days after appearance, as shown by comparing DEN-2 16681 on days 5 and 6 (Fig. 1 ). For most viruses tested, plaques were small (2 mm) and evenly distributed at first appearance. Often 100 or more distinct plaques could be counted per well (Fig. 1) . However, plaque size quickly enlarged; if assays were harvested late, crowding and over, lapping made plaque counting difficult. For example, DEN-2 strain 16681 caused small plaques on day 5 and large, fluffy plaques on day 6 (Fig. 1) . Morphological plaque differences In at least two cases of seroconversion with substantial heterotypic antibody (pairs 24010-24332 and 73106-22981), there was disagreement between the two tests as to the highest serotype antibody level, the macro test identifying DEN-1 and the BHK test identifying DEN-3. Although it is conceivable that in both tests these instances reflect secondary infection with subthreshold antibody in the first specimen and comparatively low-level antibody in the second, it is more likely that they represent primary infections with heterotype cross-reaction, perhaps in one instance because the second specimen was obtained early in convalescence. Examination of Table 2 suggests that there was substantial DEN-1/DEN-3 crossing in both tests, particularly for those specimens originally identified as seroconverting to DEN-1 (versus DEN-3) in the macro PRNT. These data cannot resolve the uncertainties about infecting serotype, but they underscore the well-known complexities in the interrelationships of the dengue serotypes.
The BHK suspension PRNT satisfies the previously mentioned criteria for an acceptable alternative to neutralization in bottles: it is of equal specificity and sensitivity and, for detecting antibody to DEN-2 virus, apparently is more sensitive. At the same time, its simplicity and ease of performance meet or exceed those of other improved tests reported in the scientific literature (1, 3, 5, 6, 9, 10) . Specifically, the BHK suspension test is preferable to the macro PRNT in the following respects: (i) it can be performed with small volumes (60 pul, versus 0.24 ml in the bottle PRNT, for screening all four dengue serotypes at 1:10 dilution); (ii) it can be interpreted at 5 to 7 days versus 14 to 21 days and can be performed more quickly, resulting in a substantial saving in personnel time; (iii) it is cost saving, requiring only 25% as much cell culture medium; (iv) it is less cumbersome, requiring about 5% as much incubator and storage space; and (v) it can be interpreted at any time and stored indefinitely for later interpretation or comparison. In the following respects it is preferable to the LLC-MK2 semimicro assay recently reported (Morens et al., submitted for publication): (i) it can be interpreted at 5 to 7 versus 14 tomeniscus gathers in the LLC-MK2 test; (v) a higher number of PFU can be added to each well, resulting in considerable benefit in test specificity and sensitivity; and (vi) the test can be interpreted at any time after staining or stored for prolonged periods. We have had encouraging preliminary results (data not shown) with early staining of plates (day 4 to 5) and use of BHK cells after short passage-incubation, suggesting that the BHK suspension test may be sufficiently flexible that in urgent diagnostic situations results could be provided in as little as 4 days after the specimen is obtained. Also, we have used the BHK PRNT extensively with Southeast Asian DEN-4 strain 4328-S and with laboratory strains of DEN-1, 2, and 3 (from Southeast Asia) and JE (Nakayama) and found morphology and time of plaque appearance to be equivalent to those of the Caribbean strains reported here.
Low cost, ease of performance, relatively short test time, and improved test sensitivity suggest that in laboratories with cell culture capability the BHK suspension PRNT will prove a sound alternative to such standard serologies as hemagglutination inhibition and complement fixation.
